Concepedia

Ericka C. Busby

EC

3

Publications

1.9K

Citations

3

H-Index

1998

Active since

Affiliations

Mayo Clinic(Current)

Ericka C. Busby is an author at Mayo Clinic specializing in cancer research, tumor biology, and cancer cell biology.

Top concepts

Publications per year

1998–2000

3

Publications

3

Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine.

Jann N. Sarkaria, Ericka C. Busby, Randal S. Tibbetts et al. · PubMed · 1999 · 1K citations

, , +17

Inhibition of phosphoinositide 3-kinase related kinases by the radiosensitizing agent wortmannin.

Jann N. Sarkaria, Randal S. Tibbetts, Ericka C. Busby et al. · PubMed · 1998 · 526 citations

, , +17

The radiosensitizing agent 7-hydroxystaurosporine (UCN-01) inhibits the DNA damage checkpoint kinase hChk1.

Ericka C. Busby, Dru F. Leistritz, Robert T. Abraham et al. · PubMed · 2000 · 316 citations

, , +18

Rows per page

1–3 of 3